Endometrial stromal sarcoma with Cd56 expression: a case report
Endometrial stromal sarcoma (ESS) is a rare malignant tumour of the endometrium, accounts for less than 1% of all uterine malignancies. Routinely, it is diagnosed morphologically, supported by immunomarkers of CD10 and vimentin. CD56 is used widely in neuroendocrine tumour. In our current practice,...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pusat Perubatan Universiti Kebangsaan Malaysia,
2018.
|
| Online Access: | Get fulltext |
| LEADER | 00954 am a22001573u 4500 | ||
|---|---|---|---|
| 001 | 12555 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Azizan N, |e author |
| 700 | 1 | 0 | |a Hayati F, |e author |
| 700 | 1 | 0 | |a Madatang A, |e author |
| 700 | 1 | 0 | |a Abu Seman F, |e author |
| 245 | 0 | 0 | |a Endometrial stromal sarcoma with Cd56 expression: a case report |
| 260 | |b Pusat Perubatan Universiti Kebangsaan Malaysia, |c 2018. | ||
| 856 | |z Get fulltext |u http://journalarticle.ukm.my/12555/1/7._azizan_n_et_al.pdf | ||
| 520 | |a Endometrial stromal sarcoma (ESS) is a rare malignant tumour of the endometrium, accounts for less than 1% of all uterine malignancies. Routinely, it is diagnosed morphologically, supported by immunomarkers of CD10 and vimentin. CD56 is used widely in neuroendocrine tumour. In our current practice, CD56 is not used to support the diagnosis of ESS. We present a case of a postmenopausal lady with advanced ESS who had expression of CD56 upon immunohistochemical study. | ||
| 546 | |a en | ||